Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Comparison of the effectiveness and safety of semaglutide versus dulaglutide for treating type 2 diabetes: a retrospective cohort study utilizing propensity score matching

Published on Chinese Journal of Pharmacoepidemiology 2024,33(6):601-611.
10896 times 2308 times

HE Lanzhi ZHOU Pengxiang HUANG Shulin LIN Chunyan LUO Haikun QI Jianying ZHANG Hongliang CHEN Xiaoyu ZHOU Ganping

Type 2 diabetes Semaglutide Dulaglutide Effectiveness Safety Propensity score matching Generalized estimation equation
Details
Practice and reflection on cultivating professional ability of hospital pharmacists based on action learning method

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1082-1088.
6606 times 1253 times

WAN Lingli ZHANG Liangming LUO Gang CHEN Xinyi LI Hongqing XING Xiangyi ZENG Qian PENG Zhengying MAO Guangming

Action learning method Pharmacists Pharmaceutical services Practicing ability Teaching and training Higher order thinking
Details
Influence of national volume-based procurement policy on the economy and use structure of anti-infective drugs in a hospital

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1072-1081.
7353 times 1257 times

CHEN Ze YAO Tiao JIN Chen LI Danjiang LI Fei HU Hua

National volume-based procurement Anti-infective drugs Branded drug Generic drug Pharmacy administration Drug economy Use structure
Details
Analysis of the prognostic value of NLR in the treatment of PD-1 inhibitors in patients with HER2-negative advanced gastric cancer

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1063-1071.
6433 times 1142 times

DOU Yalin CHENG Weili SUN Mingqi WU Shuanghong YANG Tingting LI Dapeng

Advanced gastric cancer Immunotherapy Neutrophils/lymphocytes Prognosis Chemotherapy human Epdermal growth factor receptor
Details
A pilote study of Chaiqi Ningshen Anmian Decoction combined with wrist ankle acupuncture in chronic insomnia patients with heart and spleen deficiency

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1055-1062.
6640 times 1205 times

LI Yujiao REN Shan DONG Zhizhi DUAN Na TIAN Wenwen CHEN Zhigang

Chronic insomnia Heart and spleen deficiency Chaiqi Ningshen Anmian Decoction Wrist ankle acupuncture
Details
Application value of amlodipine/atorvastatin combined with evidence-based emotional nursing mode in elderly patients with hypertension complicated by coronary heart disease

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1048-1054.
6955 times 1196 times

WU Xiangna JIN Liya LIANG Pingping LIN Duoduo ZHENG Wenxian

Amlodipine/atorvastatin Evidence-based emotional nursing mode Hypertension Coronary heart disease Elderly Compliance
Details
Efficacy of interferon α-2b combined with chlorquinaldol-promestriene on cervical intraepithelial neoplasia patients after loop electrosurgical excisional procedure

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1041-1047.
6500 times 1298 times

SU Yanyan YANG Hu

Cervical intraepithelial neoplasia Interferon α-2b Chlorquinaldol-promestriene Loop electrosurgical excisional procedure
Details
The prediction value of depressive symptom dimensions in the efficacy of high-frequency repetitive transcranial magnetic stimulation combined with flupentixol and melitracen tablets for post-stroke depression

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1034-1040.
5773 times 1082 times

JIANG Yanping ZHANG Ruilian XUE Chengchuan LIU Xianxiu

Depressive symptom dimension Repeated transcranial magnetic stimulation Flupentixol and melitracen tablets Efficacy Prediction
Details
Prevention effect of ceftriaxone sodium combined with bundle management on early ventilator-associated pneumonia

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1028-1033.
5013 times 1142 times

HE Yin GAI Tiantian HAN Zunhai

Ceftriaxone Bundle management Early ventilator-associated pneumonia Prevention Mechanical ventilation
Details
CiteSpace bibliometric analysis of safety and risk studies of antibody drugs in China

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1019-1027.
5219 times 1267 times

PENG Yue LIU Lingling CAI Yuanxuan ZHAO Yuhang SHANGGUAN Xiaofang LI Kangling CHEN Zherui LI Ke HUANG Rui LU Yuanyuan

Antibody drugs CiteSpace Safety Risk Adverse reactions Bibliometrics Drug safety Risk management
Details
Study on immune biomarker of gout and screening of related target Chinese medicine based on the xCell algorithm

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):1007-1018.
6771 times 1288 times

LI Lingqin ZHOU Ruijiao ZHANG Yanni YUAN Xinzhu

Gout Chinese medicine Bioinformatics Immune markers Arthritis Metabolic syndrome Monosodium urate Gene microarray
Details
The effect of seritaline and multidisciplinary collaborative management model on adolescents with first-episode major depression disorder

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):999-1006.
6549 times 1317 times

RU Guifang LI Yuanlin GAO Min

Major depressive disorder Sertraline Multidisciplinary collaborative management model Emotion Inflammatory factor
Details
Risk assessment and prediction model for capecitabine-induced chemotherapy-related adverse reactions in colorectal cancer patients

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):992-998.
5400 times 1223 times

CHEN Shaobo WU Xutao QIU Wenhui HU Tingting

Colorectal cancer Capecitabine Chemotherapy-induced adverse efects Risk prediction model
Details
Effect of granulocyte colony-stimulating factor combined with tadalafil on endometrial receptivity and pregnancy outcomes in patients with thin endometrium

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):984-991.
5129 times 1161 times

SHI Hongzhen SUN Lijuan WANG Lin WANG Qian ZHANG Shuang LIN Lin

Thin endometrium Granulocyte colony stimulating factor Tadalafil Endometrial receptivity Pregnancy outcome
Details
Apigenin alleviates renal cell injury and oxidative stress induced by high glucose by activating Keap1-Nrf2-ARE signaling pathway

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):975-983.
8061 times 1372 times

CHEN Yijie QUAN Zijiao ZHENG Nan XIE Yuequn

Diabetic nephropathy Oxidative stress Cell injury Apigenin Keap1-Nrf2-ARE
Details
Study on the influence of different stabilizers on the stability of quercetin nanocrystals

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):969-974.
5544 times 1354 times

DU Yukun WANG Lifu KANG Xin PAN Zhenhua DANG Yunjie

Quercetin Nanocrystals Stabilizers Povidone K30 Polosham F188 Sodium dodecyl sulfate Stability
Details
Inhibition of lupinol on the malignant progression of lung cancer A549 cells through regulating Notch signaling pathway

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):961-968.
6478 times 1217 times

YIN Bingyi LIN Hongsheng ZHANG Chuchu

Lupeol Notch signaling pathway Lung cancer cell Proliferation Apoptosis Migration Invasion
Details
The improvement of intestinal immune barrier function in immunoglobulin A nephropathy rats by Atractylolactone-III nanoparticles

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):951-960.
5251 times 1233 times

LIN Shengfen CAI Xiaoqiao LIN Yongqiang WANG Chaochao

Atractonolide III IgA nephropathy Intestinal immunity Intestinal permeability
Details
Quality analysis of Xiao’er Magan granules based on chemometrics combined with quantitative analysis of different components

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):937-950.
6764 times 1361 times

FEI Yiqin LYU Pan YANG Ping ZHAN Fangling XU Ling

Xiao’er Magan granules Chemometrics Fingerprints Difference analysis of component content Ultra-performance liquid chromatography/quadrupole time-of-flight-tandem mass spectrometry Quality analysis
Details
HPLC fingerprint and three main components determination of Modified Zengye Decoction

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):928-936.
5417 times 1408 times

LIU Shiqi WU Chuang ZHU Zhimin XU Feng CHANG Yaowen ZHANG Haiyan GOU Xiaojun

Modified Zengye Decoction Ferulic acid Aurantiamarin Harpagoside High performance liquid chromatography Fingerprint Content determination Quality control
Details